What is a Mucinous Cystic Neoplasm (MCN) of the hepatic cyst, particularly in middle-aged to older adult women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mucinous Cystic Neoplasm of the Liver

Definition and Pathologic Features

Mucinous cystic neoplasm (MCN) of the liver is a rare cystic epithelial tumor lined by mucin-producing epithelium overlying ovarian-like hypercellular stroma, occurring predominantly in middle-aged women. 1

The two pathologic hallmarks that define MCN are:

  • Presence of ovarian-like hypercellular stroma (the definitive diagnostic feature) 1
  • Absence of communication with the bile duct (distinguishes MCN from intraductal papillary neoplasms) 1

These lesions were formerly called "biliary cystadenoma" or "biliary cystadenocarcinoma" but are now classified under the unified term MCN. 1

Epidemiology and Clinical Presentation

MCNs account for less than 5% of all liver cysts and occur predominantly in middle-aged women. 1, 2

86% of MCNs are symptomatic at presentation, manifesting as: 1

  • Abdominal pain
  • Abdominal fullness
  • Early satiety (due to mass effect from large size)

Malignant Potential

The vast majority of MCNs are benign, but 3-6% harbor invasive carcinoma, typically in older patients. 1

MCNs may present with varying degrees of dysplasia: 1

  • Low-grade dysplasia
  • High-grade dysplasia
  • Invasive carcinoma

Serum tumor markers (CEA and CA 19-9) may be elevated, particularly with invasive carcinoma, but lack good diagnostic accuracy. 1

Imaging Characteristics

MCNs are typically solitary, large, well-circumscribed cystic lesions that predominantly form in the left liver lobe. 1

Key imaging features include: 1

  • Multiloculated appearance (90%) or unilocular
  • No communication with the biliary tree (upstream ductal dilatation, if present, is from mass effect)
  • Enhancing septa, mural calcifications, and mural nodules
  • Mural nodules >1 cm are associated with malignancy 1
  • Septa arise from the cyst wall without associated wall indentation 1

Worrisome Features for MCN

MRI should be used to characterize hepatic cysts with worrisome features, as it is more accurate than CT. 1

The combination of ≥1 major feature PLUS ≥1 minor feature carries 94-98% specificity for MCN: 1

Major worrisome features: 1

  • Thick septations
  • Nodularity

Minor worrisome features: 1

  • Upstream biliary dilatation
  • Thin septations
  • Internal hemorrhage
  • Perfusional change
  • <3 coexistent hepatic cysts

Diagnostic Challenges

20-50% of MCNs are not properly identified before surgery, leading to inadequate resection. 1

Distinguishing MCNs from simple hepatic cysts remains challenging and requires multidisciplinary expertise involving hepatogastroenterologists, abdominal radiologists, abdominal surgeons, and expert pathologists. 1

Complicated hepatic cysts (infection or hemorrhage) may mimic MCNs on imaging, leading to misdiagnosis. 1

Invasive MCNs can only be differentiated from non-invasive MCNs by microscopic evaluation for ovarian-type stroma, making intraoperative biopsy and frozen section essential. 2

Management

Surgical resection with complete excision is the gold standard for all suspected MCNs of the liver. 1

Surgical Approach

Formal hepatic resection or enucleation with free margins is the preferred approach, with extended hemihepatectomy sometimes required for complete removal. 1

Fenestration is inadequate and associated with high tumor recurrence rates (0-26% recurrence after incomplete resection). 1

Complete surgical removal yields good long-term outcomes with very low recurrence rates. 1 The presence of malignancy at initial resection is the most significant factor associated with poorer outcomes. 1

Recurrence with malignant transformation in patients who initially had non-malignant MCNs is rare. 1

Rationale for Aggressive Surgical Management

Despite the difficulty in establishing reliable preoperative diagnosis and the low prevalence of MCNs, the current literature provides compelling evidence for complete surgical resection due to: 1

  • Risk of malignant transformation (3-6% harbor invasive carcinoma) 1
  • High recurrence rates with incomplete resection 1
  • Inability to reliably differentiate benign from malignant MCNs on imaging alone 1, 3
  • Excellent long-term outcomes with complete resection 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Mucinous Cystic Neoplasms of the Liver.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2023

Related Questions

Can unroofing of a hepatic cyst in a middle-aged to older adult woman with a Mucinous Cystic Neoplasm (MCN) of the liver cause peritoneal carcinomatosis?
Can a middle-aged to older adult woman with a history of mucinous cystic neoplasm (MCN) and unroofing of a hepatic cyst be diagnosed with peritoneal carcinomatosis secondary to MCN?
What treatment options were missed for a 30-year-old male patient with irritable bowel syndrome (IBS) characterized by daily bloating, brain fog, fatigue, and weekly indigestion, who initially responded to pantoprazole (Proton Pump Inhibitor (PPI)) but lost efficacy after 6-8 weeks, and was subsequently prescribed venlafaxine for suspected stress-mediated symptoms?
What does a red blood cell count of 5.91, hemoglobin of 16.6, and hematocrit of 50.9 indicate in a patient with chronic liver disease and portal hypertension?
Is endovenous ablation therapy of the right anterior branch medically necessary for a 60-year-old female with a long-standing history of symptomatic varicose veins, who has failed conservative treatment with compression, has no history of Deep Vein Thrombosis (DVT), and has a Body Mass Index (BMI) of 30.73, with symptoms of pain, edema, heaviness, achiness, and sensitivity in the lower extremities?
What are the best treatment options for a patient with pox scars seeking removal?
What are the causes of vertigo and tinnitus in older adults?
What is the recommended duration for using peripheral intravenous (IV) vasopressors, such as norepinephrine or dopamine, in hemodynamically unstable patients with conditions like septic shock or severe hypotension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.